PIC50: An open source tool for interconversion of PIC50 values and IC50 for efficient data representation and analysis
Thakur, A.; Kumar, A.; Sharma, V. k.; Mehta, V.
Show abstract
Half-maximal inhibitory concentration (IC50) is used to determine the potency of a drug against a variety of enzymes/ biological targets associated with the pathogenesis of multiple disorders. The IC50 values can be depicted in multiple ways, which makes it difficult to analyze the results presented in different concentrations. Representing data in the form of PIC50 values depicting the IC50 values as the negative logarithm of IC50 in molar concentration is considered to be a better approach as it not only makes data easily understandable but also eliminates the possibility of errors in data representation and reproducibility. Considering the importance of data representation for a better understanding of data and comparing efficacy and potency of the drugs, besides, the significance of PIC50 value in the field of CADD, we found that at present there is no single open-source software available to convert the IC50 values to PIC50 values and vice versa from millimolar to picomolar range. Therefore, in the present study, we develop a tool that could help researchers to interconvert IC50 values and PIC50 values in a reliable way to eliminate the possibility of errors. We validated our tool through three case studies where the data generated by our tool was found to be 100% accurate. Moreover, we present a case where data was published in literature with errors in calculated PIC50 values and demonstrated the importance and reliability of our tool.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Pharmacophore modeling, 2D-QSAR, Molecular Docking and ADME studies for the discovery of inhibitors of PBP2a in MRSA 98%
- A program to automate the discovery of drugs for West Nile and Dengue virus -- programmatic screening of over a billion compounds on PubChem, generation of drug leads and automated In Silico modelling 97%
- Target2DeNovoDrugPropMax : a novel programmatic tool incorporating deep learning and in silico methods for automated de novo drug design for any target of interest 97%
Similar papers in this journal
- Identification of Natural Antiviral Drug Candidates Against Tilapia Lake Virus: Computational Drug Design Approaches 96%
- Deep learning based predictive modeling to screen natural compounds against TNF-alpha for the potential management of Rheumatoid Arthritis: Virtual screening to comprehensive in silico investigation 95%
- Antivirals for Monkeypox Virus: Proposing an Effective Machine/Deep Learning Framework 95%
Similar papers in this journal
- RAFTS3G - An efficient and versatile clustering software to analyses in large protein datasets 93%
- PDAUG - a Galaxy based toolset for peptide library analysis, visualization, and machine learning modeling 93%
- vCOMBAT: a Novel Tool to Create and Visualize a COmputational Model of Bacterial Antibiotic Target-binding 93%
Similar papers in this journal
- Primary Target Prediction of Bioactive Molecules from Chemical Structure 96%
- Innovative, rapid, high throughput method for drug repurposing in a pandemic - a case study of SARS-CoV-2 and COVID-19 94%
- SAMbinder: A web server for predicting SAM binding residues of a protein from its amino acid sequence 93%
Similar papers in this journal
- DenovoProfiling: a webserver for de novo generated molecule library profiling 94%
- Drug repositoning or target repositioning: a structural perspective of drug-target-indication relationship for available repurposed drugs. 93%
- Computationally Grafting an IgE Epitope onto a Scaffold: Implications for a Pan Anti-Allergy Vaccine Design 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.